Abstracts tagged "fibromyalgia"

Abstract Number: 0122 • ACR Convergence 2021
Clinical Impact of a Digital Behavioral Therapy for Fibromyalgia Management: A Randomized Controlled Trial
Stephanie Catella¹, Michael Gendreau², Nicolette Vega¹, Allison Kraus¹, Michael Rosenbluth¹, Sherry Soefje³, Shishuka Malhotra⁴ and Lesley Arnold⁵, ¹Swing Therapeutics, San Francisco, CA, ²Gendreau Consulting, LLC, Poway, CA, ³Excell Research, Oceanside, CA, ⁴Neuro-Behavioral Clinical Research, North Canton, OH, ⁵University of Cincinnati, Cincinnati, OH
Background/Purpose: Recommendations for fibromyalgia management include both pharmacologic and nonpharmacologic treatments. Cognitive behavioral therapy (CBT) has demonstrated level 1A evidence for fibromyalgia management, though access…
Abstract Number: 0123 • ACR Convergence 2021
Vestibulocortical Stimulation with Caloric Irrigation Reduces Pain and Improves Subjective Well-Being in Fibromyalgia: An Open-Label Pilot Trial
Michael Kaplan¹, Celine Zhou¹, Emily Carroll¹, Alan Weinberg², Daniel Clauw³, Trung Thanh Ngo⁴ and Ioannis Tassiulas⁵, ¹The Mount Sinai Hospital, Manhattan, NY, ²The Mount Sinai Hospital, New York, NY, ³University of Michigan, Ann Arbor, MI, ⁴University of Queensland & Translational Research Institute, Woolloongabba, Australia, ⁵Icahn School of Medicine at Mount Sinai, New York, NY
Background/Purpose: Safe and effective therapies for fibromyalgia (FM) remain a major unmet clinical need. Vestibulocortical stimulation (VCS) via caloric irrigation is a safe, inexpensive, non-invasive…
Abstract Number: 0125 • ACR Convergence 2021
Body Mass Composition in Post-menopausal Women with Fibromyalgia: Preliminary Results from a Cross-sectional Monocentric Study
Sabrina Paolino¹, Elvis Hysa², MASCARO ROSSELLA³, Andrea Casabella¹, LUCA CARMISCIANO⁴, Emanuele Gotelli¹, Carmen Pizzorni⁵, Alberto Sulli¹, Vanessa Smith⁶ and Maurizio Cutolo¹, ¹Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Polyclinic San Martino Hospital, Genoa, Italy, ²Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology Department of Internal Medicine University of Genova Italy IRCCS Polyclinic San Martino, Genoa, Italy, ³Laboratory od Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, Italy - IRCCS Rheumatology Unit San Martino Polyclinic, Genoa, Italy, ⁴Department of Health Sciences ( DISSAL), Section of Biostatistics, University of Genova, Genova, Italy, ⁵Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Dept. Internal Medicine, University of Genova, IRCCS Polyclinic San Martino Hospital, Genoa, Italy, ⁶Department of Rheumatology and Internal Medicine, Ghent University Hospital, Ghent, Belgium
Background/Purpose: Fibromyalgia (FM) is characterized by chronic musculoskeletal widespread pain, fatigue, sleep disturbances and functional symptoms. The primary endpoint of our study aimed to determine…
Abstract Number: 0126 • ACR Convergence 2021
Prevalence of Dyslipidemia in Fibromyalgia: A Single Center Case Control Study from South India
Mithun CB¹, Sandeep Surendran², Sumanth Madan², Arun Tiwari³, Spoorthy Raj², Sekhar Easwar² and Greeshma Ravindran², ¹Amrita Institute of Medical Sciences, Muvattupuzha, India, ²Amrita Institute of Medical Sciences, Kochi, India, ³Amrita Institute of Medical Sciences, Ernakulam, India
Background/Purpose: Fibromyalgia (FM), a condition characterized by chronic widespread pain, has implications beyond functional disability. FM has been associated with an increased risk of cardiovascular…
Abstract Number: 0127 • ACR Convergence 2021
Interleukin 1 Receptor Antagonist (IL-1Ra) Variable Number of Tandem Repeat (VNTR) Polymorphism in Fibromyalgia Patients in South India
Arun Tiwari¹, Mithun CB², Lalitha Biswas³, Sandeep Surendran³, Vishal Marwaha³, Pranav Chickermane³ and Amisha Shahul³, ¹Amrita Institute of Medical Sciences, Ernakulam, India, ²Amrita Institute of Medical Sciences, Muvattupuzha, India, ³Amrita Institute of Medical Sciences, Kochi, India
Background/Purpose: Interleukin-1 receptor antagonist (IL-1Ra) variable number of tandem repeats (VNTR) polymorphism is a known to influence the production of IL-1Ra and has been considered…
Abstract Number: 0474 • ACR Convergence 2021
Correlation of Fibromyalgia Survey Questionnaire and Quantitative Sensory Testing Among Patients with Active Rheumatoid Arthritis
Meriah Moore¹, Beth Wallace², Jing Song³, Lutfiyya Muhammad⁴, Andrew Heisler⁵, Daniel Clauw¹, Marcy Bolster⁶, Wendy Marder¹, Tuhina Neogi⁷, Alyssa Wohlfahrt⁸, Dorothy Dunlop⁹ and Yvonne Lee⁹, ¹University of Michigan, Ann Arbor, MI, ²Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, ³Northwestern University, Worthington, IL, ⁴Northwestern University Feinberg School of Medicine, Chicago, IL, ⁵Bronson Rheumatology Specialists, Kalamazoo, MI, ⁶Massachusetts General Hospital, Boston, MA, ⁷Boston University School of Medicine, Boston, MA, ⁸Tufts University School of Medicine, Boston, MA, ⁹Northwestern University, Chicago, IL
Background/Purpose: Patients with rheumatoid arthritis (RA) commonly demonstrate disordered pain processing, termed central sensitization (CS). CS is typically measured using quantitative sensory testing (QST), which…
Abstract Number: 1273 • ACR Convergence 2020
The Impact of the COVID-19 Pandemic on the Fibromyalgia Symptoms of SLE Patients
Rebecca Sadun¹, Jennifer Rogers², Kai Sun¹, Karissa Grier¹, Lisa Criscione-Schreiber³, Mithu Maheswaranathan¹, Jayanth Doss¹ and Megan Clowse⁴, ¹Duke University, Durham, NC, ²Duke, Durham, NC, ³Duke University School of Medicine, Durham, NC, ⁴Duke University, Chapel Hill, NC
Background/Purpose: Many patients with SLE experience symptoms of chronic pain and fatigue, often meeting criteria for fibromyalgia (FM). In this study, we sought to examine…
Abstract Number: 1316 • ACR Convergence 2020
Patient Perceptions of Fibromyalgia Symptoms and the Overlap with Axial Spondyloarthritis
Kelly Gavigan¹, William Nowell², Regan Reynolds¹, Laura Stradford¹, Jeffrey R Curtis³ and Alexis Ogdie⁴, ¹Global Healthy Living Foundation, Upper Nyack, NY, ²Global Healthy Living Foundation, New York City, NY, ³Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁴University of Pennsylvania, Philadelphia, PA
Background/Purpose: In clinical practice, it is often challenging to distinguish fibromyalgia syndrome (FMS) from axial spondyloarthritis (axSpA), which includes ankylosing spondylitis and non-radiographic axSpA. Early stages…
Abstract Number: 0023 • ACR Convergence 2020
Hypophosphatasia May Be Misdiagnosed as Fibromyalgia: A Single Center Experience
Patil Injean¹, Sandy Lee¹ and Christina Downey¹, ¹Loma Linda University Medical Center, Redlands, CA
Background/Purpose: Hypophosphatasia (HPP) is a rare disease characterized by incomplete or defective bone mineralization due to a mutation in the alkaline phosphatase gene (ALPL). Given…
Abstract Number: 1317 • ACR Convergence 2020
A Large Agreement Between the Pain Points of the ACR 1990 Fibromyalgia Criteria and the MASES Enthesitis Score Is Observed in Patients with Axial Spondylitis, Including in Patients Without Concomitant Fibromyalgia
Faten Hamitouche¹, Clementina Lopez-Medina², Laure Gossec³, Serge Perrot⁴, Maxime Dougados⁵ and Anna Molto⁶, ¹Rheumatology Department, Cochin Hospital, Paris, Ile-de-France, France, ²Rheumatology Department, Cochin Hospital, Paris, Paris, France, ³Sorbonne Université and Hôpital Universitaire Pitié Salpêtrière, Paris, France, ⁴Paris Descartes University, Paris, Ile-de-France, France, ⁵Université de Paris, Department of Rheumatology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France, ⁶Rheumatology Department, Cochin Hospital, APHP, Paris, France, Paris, France
Background/Purpose: Enthesitis is the hallmark lesion in Spondyloarthritis (SpA). The Maastricht Ankylosing Spondylitis Enthesitis score (MASES), which assesses 13 enthesitic sites, is the most widely…
Abstract Number: 0024 • ACR Convergence 2020
An International Delphi Consensus on Non-pharmacological Interventions for Fibromyalgia
Burak Kundakci¹, Michelle Hall¹, Fabiola Atzeni², Jaime C. Branco³, Dan Buskila⁴, Daniel Clauw⁵, Leslie J. Crofford⁶, Mary-Ann Fitzcharles⁷, Vasileios Georgopoulos⁸, Robert D. Gerwin⁹, Eva Kosek¹⁰, Gary Macfarlane¹¹, Caroline Neal¹², Nathan J. Rudin¹³, Sarah Ryan¹⁴, José A. P. da Silva¹⁵, Ann Taylor¹⁶, Dennis C. Turk¹⁷, Daniel Whibley¹⁸, Michael Doherty¹⁹, Weiya Zhang²⁰ and Abhishek Abhishek¹, ¹University of Nottingham, Nottingham, United Kingdom, ²Rheumatology Unit, University of Messina, Messina, Italy, ³3.CEDOC, NOVA Medical School, Faculdade de Ciências Médicas da Universidade NOVA de Lisboa, Lisboa, Portugal; 7.Hospital Egas Moniz (CHLO) (Rheumatology Department), Lisboa, Portugal, Lisboa, Portugal, ⁴Ben Gurion University of the Negev, Beer – Sheva, Israel, Beer-Sheva, Israel, ⁵Michigan Medicine, Ann Arbor, MI, ⁶Vanderbilt University Medical Center, Nashville, TN, ⁷McGill University, montreal, Canada, ⁸University of Nottingham, Nottingham, ⁹Johns Hopkins University, Baltimore, ¹⁰Karolinska Institutet, Stockholm, Sweden, ¹¹University of Aberdeen, Aberdeen, Scotland, United Kingdom, ¹²Primary Integrated Community Services Ltd, Nottingham, United Kingdom, ¹³University of Wisconsin, Madison, ¹⁴Midlands NHS Foundation Trust and Keele University, Stoke on trent, United Kingdom, ¹⁵9.Centro Hospitalar e Universitário Coimbra (Rheumatology Department), Coimbra, Portugal, Coimbra, Portugal, ¹⁶Cardiff University School of Medicine, Cardiff, United Kingdom, ¹⁷University of Washington School of Medicine, Seattle, WA, ¹⁸University of Aberdeen, Ann Arbor, MI, ¹⁹Academic Rheumatology, School of Medicine, University of Nottingham, UK, Nottingham, England, United Kingdom, ²⁰Academic Rheumatology, School of Medicine, University of Nottingham, UK, Nottingham, United Kingdom
Background/Purpose: Fibromyalgia (FM) impacts directly on health and quality of life (QoL) of patients and associates with a large health economic burden. Non-pharmacological interventions are…
Abstract Number: 1733 • ACR Convergence 2020
Patients with Rheumatoid Arthritis and Comorbid Depression Have High Levels of RAPID3 (Routine Assessment of Patient Index Data) and FAST3 (Fibromyalgia Assessment Screening Index) on a Multidimensional Health Assessment Questionnaire (MDHAQ)
Rosa Morlà¹, Tengfei Li², Jose Inciarte-Mundo³, Isabel Castrejon Fernandez⁴, Jose Gómez-Puerta⁵, Raimon Sanmartí⁵ and Theodore Pincus⁶, ¹Hospital Universitari Clínic de Barcelona, Barcelona, Spain, ²Georgetown University, Washigton, ³Hospital Universitari Clínic de Barcelona, Barcelona, ⁴Hospital General Universitario Gregorio Marañón, Chicago, IL, ⁵Hospital Universitari Clínic de Barcelona, Barcelona, Catalonia, Spain, ⁶Rush University Medical Center, Chicago, IL
Background/Purpose: Patients with rheumatoid arthritis (RA) have higher comorbid depression and/or fibromyalgia (FM) than the general population. A multidimensional health-assessment questionnaire (MDHAQ) includes two queries…
Abstract Number: 0025 • ACR Convergence 2020
Clinical and Psychological Assessment of Rheumatoid Arthritis Patients with Fibromyalgia: A Real World Study
Tian Liu¹, Chao Gao¹ and Lihong Chen¹, ¹hospital, Beijing, China (People's Republic)
Background/Purpose: To assess the clinical features and psychological status of the rheumatoid arthritis(RA) patients with fibromyalgia(FM) in a real-world observational setting.Methods: Between December 2018 to…
Abstract Number: 1846 • ACR Convergence 2020
Evaluating the Risk of QT-prolongation Associated with Hydroxychloroquine Use with and Without Antidepressants in SLE Patients with Fibromyalgia
Jacinta Renaldi¹, Fotios Koumpouras¹ and Mei Xue Dong¹, ¹YALE SCHOOL OF MEDICINE, New Haven, CT
Background/Purpose: Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease predominantly affecting woman of child-bearing age. Concurrent fibromyalgia syndrome (FMS) has been reported in…
Abstract Number: 0026 • ACR Convergence 2020
A Modified Version of the 2016 ACR Fibromyalgia Criteria Cognitive Items Results in Stronger Correlation Between Subjective and Objective Measures of Cognitive Impairment
Valerie Aloush¹, Chen Yaalon², Sheer Raev², Noy Sobol², Jacob Ablin¹, Ran Shorer³ and Odelia Elkana², ¹Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, ²Academic College Tel Aviv Jaffa, Tel Aviv, Israel, ³Tel Aviv Medical Center, Tel Aviv, Israel
Background/Purpose: In a previous study, we showed that the subjective item assessing cognitive impairment (SSS-Cog) for fibromyalgia (FM) did not correlate with objective cognitive measures.…

« Previous Page
1
…
7
8
9
10
11
…
25
Next Page »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].